Merited Wealth’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.04M Sell
902
-3
-0.3% -$3.54K 0.72% 28
2026
Q2
$1.09M Hold
905
– – 0.77% 28
2026
Q1
$832K Hold
905
– – 0.69% 38
2025
Q4
$973K Buy
+905
New +$865K 0.9% 34

Other funds holding LLY

Merited Wealth's LLY Position: Q3 2026 in Review

Merited Wealth reduced its Eli Lilly (LLY) stake by 0.33% in Q3 2026, selling an estimated $3.54K and leaving 902 shares worth $1.04M. The position accounts for 0.72% of the portfolio, ranked #28.

Merited Wealth first reported a position in LLY in Q4 2025 and has held it in 4 quarters since. The position peaked at $1.09M in Q2 2026. 4,631 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Merited Wealth held 902 shares of Eli Lilly worth $1.04M as of Q3 2026.
  • Merited Wealth sold 3 Eli Lilly shares in Q3 2026, an estimated $3.54K.
  • Eli Lilly made up 0.72% of Merited Wealth's portfolio in Q3 2026, its #28 holding.
  • Merited Wealth first reported a position in Eli Lilly in Q4 2025 and has held it in 4 quarters since.
  • Merited Wealth's Eli Lilly position peaked at $1.09M in Q2 2026.
  • 4,631 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Merited Wealth's 13F filing for Q3 2026, filed 13 Oct 2026.